-
Complicated Urinary Tract Infections Market Report 2034: Epidemiology, Therapies, Latest FDA Approvals by DelveInsight
13 Jan 2025 12:45 GMT
… , Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, … Infections Marketed Drugs
RECARBRIO (imipenem, cilastatin, … treatment market, visit @ Complicated Urinary Tract Infections Clinical Trials … Infections Current Treatment and Medical Practices
10. …
-
Imipenem-Cilastatin-Relebactam, the New Go-To for Pneumonia?
02 Jan 2025 08:21 GMT
… multinational phase 3 trial, imipenem-cilastatin-relebactam demonstrated … treatment, microbiological response rates were 48.8% in the imipenem … drug-related adverse events was similar across the treatment … and Critical Care Medicine, Ruijin Hospital, …
-
India needs new drugs, improve infection control practices to thwart AMR: Dr Prabhu Vinayagam
16 Dec 2024 04:34 GMT
… of existing antibiotics like imipenem and approved for use …
Pharmaceutical companies focusing on AMR are developing new drugs to … medicines that work globally but also specifically tailor treatments … are not many clinical trials happening to combat AMR. …
-
More Bugs, No Drugs: The Growing Threat of Antibiotic Resistance
04 Dec 2024 15:23 GMT
… that infectious disease doctors continually harp about,” … are different from other medications, such as pain … drugs,” he explained. These include drugs like cefiderocol, imipenem- … researchers are exploring alternative treatments, such as bacteriophage therapy …
-
Cefiderocol in the Successful Treatment of Complicated Hospital-Acquired K. pneumoniae NDM, OXA48 Intraabdominal Infection
23 Nov 2024 08:44 GMT
… also approved by FDA for the treatment of complicated … sepsis.
Patient’s medical history included end-stage … colistin (in combination treatment with other drugs depending on the … , meropenen-vaborbactam, and imipenem-relebactam in combination with aztreonam …
-
Gram-Negative Bloodstream Infections in a Medical Intensive Care Unit: Epidemiology, Antibiotic Susceptibilities, and Risk Factors for in-Hospital Death
19 Nov 2024 07:04 GMT
… to at least one carbapenem (imipenem, meropenem, or doripenem).20 Appropriate … defined when antimicrobial treatment regimens included at least 1 drug displaying in … antibiotics given consistent with current medical criteria.11
Microbiologic Studies
The …
-
Distribution of Pathogenic Bacteria and Drug Resistance in ICU of a Newly Built Hospital
09 Nov 2024 09:47 GMT
… for Hospital Infections (Trial)” issued by the … ampicillin, sulbactam, ciprofloxacin, imipenem, cefepime, ceftazidime and ceftriaxone … as the preferred drugs for treatment.14 The number … anonymously through an electronic medical record information system. …
-
Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
02 Aug 2024 11:37 GMT
… “Evaluate Canadian Biotechnologies with Randomized Controlled Trials” (October 2023 … a wide range of pharmaceutical drugs such as antibiotics ( … imipenem, a β-lactam antibiotic used for the treatment …
The science and medical contents of this release …
-
Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
02 Aug 2024 11:20 GMT
… “Evaluate Canadian Biotechnologies with Randomized Controlled Trials” (October 2023 … a wide range of pharmaceutical drugs such as antibiotics ( … imipenem, a β-lactam antibiotic used for the treatment … The science and medical contents of this release …
-
Spero’s stock slides after antibiotic flops in Phase II trial
30 Oct 2024 16:49 GMT
… antibiotics combination, intravenous imipenem and cilastatin, in … no alternative antibacterial treatment options.
Whilst AN2 … Drug Administration (FDA) to start a Phase II trial. However, Spero noted that trial … the list of pharmaceutical companies such as …
About
© 1995-2025